The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comprehensive characterization of cisplatin-related hearing loss in U.S. and Canadian Testicular Cancer Survivors (TCS).
 
Heather E. Wheeler
No Relationships to Disclose
 
Lois B. Travis
No Relationships to Disclose
 
Amy Budnick
No Relationships to Disclose
 
Darren Richard Feldman
Consulting or Advisory Role - Bayer; Gilead Sciences (I)
Research Funding - Novartis
 
Lawrence H. Einhorn
Stock and Other Ownership Interests - Amgen; Biogen
Speakers' Bureau - Celgene; ZIOPHARM Oncology
 
Robert James Hamilton
Consulting or Advisory Role - Bayer; Janssen
 
David J. Vaughn
No Relationships to Disclose
 
Clair Beard
No Relationships to Disclose
 
Chunkit Fung
Stock and Other Ownership Interests - GlaxoSmithKline
Consulting or Advisory Role - Dendreon; Janssen Scientific Affairs
Research Funding - Astellas Pharma (Inst)
 
Eileen Johnson
No Relationships to Disclose
 
Malcolm J. Moore
No Relationships to Disclose
 
Deepak M. Sahasrabudhe
Consulting or Advisory Role - Dendreon (Inst)
 
Sophie D. Fossa
No Relationships to Disclose
 
Howard D. Sesso
Research Funding - Pfizer (Inst)
 
M. Eileen Dolan
Research Funding - Insys Therapeutics (Inst)
Expert Testimony - Pfizer
 
Robert D Frisina
Research Funding - Autifony Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Patents in Progress (Inst)